350 views | 5 months ago
Prof. Tony Mok discusses the benefits of biomarker testing for patients with lung cancer. He provides an overview of the value of genomic profiling in the first-line setting and highlights the importance...
968 views | 5 months ago
The Ontario Institute for Cancer Research (OICR) is working to better understand tumor biology and improve cancer care through the use of genomics. Their partner at Princess Margaret Cancer Centre,...
198 views | 6 months ago
El Perfil Genómico Integral (PGI) del ADN tumoral circulante (ctDNA) obtenido mediante biopsia líquida sanguínea proporciona resultados importantes para informar la selección de terapias posteriores....
623 views | 6 months ago
Comprehensive Genomic Profiling (CGP) of circulating tumor DNA (ctDNA) from blood liquid biopsy provides important results to inform subsequent therapy selection. In this video interview, Dr. Atocha...
23144 views | 6 months ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
1143 views | 6 months ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
304 views | 6 months ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
230 views | 6 months ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...